The first clinical study to put induced pluripotent stem (iPS) cells into humans is soon to get under way in Japan, where an institutional review board at the Institute for Biomedical Research and Innovation gave conditional approval.
Bone marrow stem cells may provide a way to target and treat inactive tuberculosis, which can hide in the body and emerge later on down the road, well after aggressive drug therapy.
Embryonic stem cell research has yet to live up to all the hype. So far, human embryonic stem cells, or hESCs, haven't yielded any cures or therapies to treat diseases. Read more >>
Stem cell research with rats may provide hope to stroke victims. In rats, stem cells repaired brain and nerve damage after a stroke, returning the animals to near normal within just a couple of weeks.
The La Jolla, CA-based Salk Institute for Biological Studies has landed a $42 million grant to establish the Helmsley Center for Genomic Medicine. The award, from The Leona M. and Harry B. Helmsley Charitable Trust, is the biggest in Salk's history.
Stem cell-based therapeutics are a fast-growing area of early-stage biotech research, but they need better production methods to enable large-scale R&D.
Stem cells from blood vessels could reduce or even prevent heart damage in people with the inherited muscle-wasting disease Duchenne muscular dystrophy.
In a mouse study of amyotrophic lateral sclerosis, injected neural stem cells moved to the spinal cord and multiplied, extending life span 20 days and improving muscle function 15%.
A cell transplant has restored sight in totally blind mice.
By using stem cell technology, two teams of Japanese researchers have been able to rejuvenate immune cells, pointing to a possible route to boost patients' inbuilt immune responses and allowing them to tackle aggressive onslaughts like HIV infections and cancer.